相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。BRAF V600E expression and distribution in desmoplastic infantile astrocytoma/ganglioglioma
C. Koelsche et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2014)
Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells
Christian Koelsche et al.
ACTA NEUROPATHOLOGICA (2013)
BRAFV600E mutation is a negative prognosticator in pediatric ganglioglioma
Sonika Dahiya et al.
ACTA NEUROPATHOLOGICA (2013)
Dysembryoplastic Neuroepithelial Tumors Share with Pleomorphic Xanthoastrocytomas and Gangliogliomas BRAFV600E Mutation and Expression
Celine Chappe et al.
BRAIN PATHOLOGY (2013)
International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: A Task Force report from the ILAE Commission on Diagnostic Methods
Ingmar Bluemcke et al.
EPILEPSIA (2013)
mTOR signaling for biological control and cancer
Anya Alayev et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Differential expression of major histocompatibility complex class I in developmental glioneuronal lesions
Avanita S. Prabowo et al.
JOURNAL OF NEUROINFLAMMATION (2013)
To BRAF or Not to BRAF: Is That Even a Question Anymore?
Craig Horbinski
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2013)
LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR)
Andrey Korshunov et al.
ACTA NEUROPATHOLOGICA (2012)
A developmental and genetic classification for malformations of cortical development: update 2012
A. James Barkovich et al.
BRAIN (2012)
Long-Term Epilepsy-Associated Tumors
Maria Thom et al.
BRAIN PATHOLOGY (2012)
Finding a better drug for epilepsy: The mTOR pathway as an antiepileptogenic target
Aristea S. Galanopoulou et al.
EPILEPSIA (2012)
mTOR Pathway Overactivation in BRAF Mutated Papillary Thyroid Carcinoma
Alexandra Faustino et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Finding the epileptogenesis switch
Annamaria Vezzani
NATURE MEDICINE (2012)
Diffuse form of dysembryoplastic neuroepithelial tumour: the histological and immunohistochemical features of a distinct entity showing transition to dysembryoplastic neuroepithelial tumour and ganglioglioma
I. Bodi et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2012)
Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody
David Capper et al.
ACTA NEUROPATHOLOGICA (2011)
Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma
Genevieve Schindler et al.
ACTA NEUROPATHOLOGICA (2011)
mTOR signaling in disease
Eva Dazert et al.
CURRENT OPINION IN CELL BIOLOGY (2011)
The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission
Ingmar Bluemcke et al.
EPILEPSIA (2011)
Functional characterization of a BRAF insertion mutant associated with pilocytic astrocytoma
Anja E. Eisenhardt et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
One Hundred and One Dysembryoplastic Neuroepithelial Tumors: An Adult Epilepsy Series With Immunohistochemical, Molecular Genetic, and Clinical Correlations and a Review of the Literature
Maria Thom et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
The role of inflammation in epilepsy
Annamaria Vezzani et al.
NATURE REVIEWS NEUROLOGY (2011)
Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis
Sharon S. McDaniel et al.
NEUROSCIENCE LETTERS (2011)
mTOR: A pathogenic signaling pathway in developmental brain malformations
Peter B. Crino
TRENDS IN MOLECULAR MEDICINE (2011)
Pi3K-mTOR Signaling and AMOG Expression in Epilepsy-associated Glioneuronal Tumors
Karin Boer et al.
BRAIN PATHOLOGY (2010)
Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias
Anand Iyer et al.
EPILEPSIA (2010)
Early Progenitor Cell Marker Expression Distinguishes Type II From Type I Focal Cortical Dysplasias
Ksenia A. Orlova et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2010)
Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas
Margaret J. Dougherty et al.
NEURO-ONCOLOGY (2010)
The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer
X. B. Trinh et al.
BRITISH JOURNAL OF CANCER (2009)
Oncogenic B-RAF Negatively Regulates the Tumor Suppressor LKB1 to Promote Melanoma Cell Proliferation
Bin Zheng et al.
MOLECULAR CELL (2009)
Uncoupling of the LKB1-AMPKα Energy Sensor Pathway by Growth Factors and Oncogenic BRAFV600E
Rosaura Esteve-Puig et al.
PLOS ONE (2009)
The multiple facets of mTOR in immunity
Thomas Weichhart et al.
TRENDS IN IMMUNOLOGY (2009)
Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells
Frank Schmitz et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
The mTOR pathway and its role in human genetic diseases
Margit Rosner et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2008)
The RSK family of kinases: emerging roles in cellular signalling
Rana Anjum et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
MOLECULAR GENETIC ANALYSIS IN A CASE OF GANGLIOGLIOMA: IDENTIFICATION OF A NEW MUTATION
Antonio De Tommasi et al.
NEUROSURGERY (2008)
The mTOR pathway as a potential target for the development of therapies against neurological disease
Daniel Zemke et al.
DRUG NEWS & PERSPECTIVES (2007)
Co-expression of cyclin D1 and phosphorylated ribosomal S6 proteins in hemimegalencephaly
Eleonora Aronica et al.
ACTA NEUROPATHOLOGICA (2007)
Differential Pi3K-pathway activation in cortical tubers and focal cortical dysplasias with balloon cells
Volker Schick et al.
BRAIN PATHOLOGY (2007)
NRAS and BRAF mutations in melanoma turnours in re ation to clinical characteristics:: a study based on mutation screening by pyrosequencing
Esther Edlundh-Rose et al.
MELANOMA RESEARCH (2006)
The IL-1β system in epilepsy-associated malformations of cortical development
T. Ravizza et al.
NEUROBIOLOGY OF DISEASE (2006)
Expression of CD34 as a novel marker for glioneuronal lesions associated with chronic intractable epilepsy
P. Deb et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2006)
Hamartin and tuberin modulate gene transcription via β-catenin
Jaroslaw Jozwiak et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Ganglioglioma arising in a Peutz-Jeghers patient: a case report with molecular implications
Nicoletta Resta et al.
ACTA NEUROPATHOLOGICA (2006)
Molecular neuropathology of epilepsy-associated glioneuronal malformations
AJ Becker et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status
Wei Qi Li et al.
MOLECULAR CANCER (2006)
Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease
A Astrinidis et al.
ONCOGENE (2005)
Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways
DJ Kwiatkowski et al.
HUMAN MOLECULAR GENETICS (2005)
Aberrant β-catenin signaling in tuberous sclerosis
BC Mak et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Distribution, characterization and clinical significance of microglia in glioneuronal tumours from patients with chronic intractable epilepsy
E Aronica et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2005)
Phosphorylation of tuberin as a novel mechanism for somatic inactivation of the tuberous sclerosis complex proteins in brain lesions
S Han et al.
CANCER RESEARCH (2004)
CD34-immunoreactive balloon cells in cortical malformations
S Fauser et al.
ACTA NEUROPATHOLOGICA (2004)
B-Raf specific antibody responses in melanoma patients -: art. no. 62
J Fensterle et al.
BMC CANCER (2004)
Immunogenicity of constitutively active V599EBRaf
MH Andersen et al.
CANCER RESEARCH (2004)
The LKB1 tumor suppressor negatively regulates mTOR signaling
RJ Shaw et al.
CANCER CELL (2004)
The reelin pathway components disabled-1 and p35 in gangliogliomas -: a mutation and expression analysis
R Kam et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2004)
Phosphatidic acid regulates systemic inflammatory responses by modulating the Akt-mammalian target of rapamycin-p70 S6 kinase 1 pathway
HK Lim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Expression and cell distribution of group I and group II metabotropic glutamate receptor subtypes in Taylor-type focal cortical dysplasia
E Aronica et al.
EPILEPSIA (2003)
Mutational analysis of TSC1 and TSC2 genes in gangliogliomas
AJ Becker et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2001)
Molecular analysis of the TSC1 and TSC2 tumour suppressor genes in sporadic glial and glioneuronal tumours
L Parry et al.
HUMAN GENETICS (2000)